Union Pharmacist Company for Medical Services and Investment (UPMS) turned profitable at EGP 5.616 million in 2024, compared to net losses of EGP 1.698 million in 2023
Updated 4/29/2025 11:37:00 AM
Union Pharmacist Company for Medical Services and Investment’s (UPMS) board members agreed to raise the authorized capital to EGP 100 million from EGP 30 million
Updated 12/25/2024 11:01:00 AM
Union Pharmacist Company for Medical Services and Investment (UPMS) posted an 89.97% year-on-year (YoY) decline in net losses after tax for the first half (H1) of 2024.
Updated 8/15/2024 9:50:00 AM
Union Pharmacist Company for Medical Services and Investment (UPMS) posted a 67.5% year-on-year (YoY) decline in net losses after tax for the first quarter (Q1) of 2024.
Updated 5/28/2024 2:48:00 AM
Union Pharmacist Company for Medical Services and Investment (UPMS) posted a 35.57% year-on-year (YoY) drop in net losses in 2023, according to the financial statement filed to the Egyptian Exchange (EGX).
Updated 4/1/2024 9:39:00 AM
Union Pharmacist Company for Medical Services and Investment (UPMS) recorded a net profit after tax of EGP 827.995 in the nine months ended September 30th, versus net losses of EGP 2.271 million in the year-ago period, according to the company’s financial indicators filed to the Egyptian Exchange (EGX) on November 13th.
Updated 11/13/2023 10:14:00 AM
Established in 2008 and listed in 2016, Union Pharmacist operates within the pharmaceuticals, biotechnology, and life sciences sectors.
Updated 5/30/2023 11:32:00 AM
Union Pharmacist Company for Medical Services and Investment (UPMS) incurred EGP 2.636 million in consolidated net loss after tax in 2022, versus EGP 109,632 in net profits after tax, according to the financial statement sent to the bourse on March 29th.
Updated 3/29/2023 10:24:00 AM